Kevzara Archives -

Roche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to

Actemra shortage spills over to include Sanofi’s rival Kevzara

https://pharmaphorum.com/news/actemra-shortage-spills-over-to-include-sanofis-rival-kevzara/

New data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

https://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/

Sanofi has drawn another blank in its attempt to repurpose its IL-6 drug Kevzara to tackle the extreme

Sanofi/Regeneron’s Kevzara fails again in serious COVID-19 cases

https://pharmaphorum.com/news/sanofi-regenerons-kevzara-fails-again-in-serious-covid-19-cases/

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trial

https://pharmaphorum.com/news/il-6-hypothesis-looking-shaky-as-kevzara-fails-covid-19-trial/

Kevzara